Exelixis Inc (NAS:EXEL)
$ 36.115 0.265 (0.74%) Market Cap: 10.31 Bil Enterprise Value: 9.21 Bil PE Ratio: 23.15 PB Ratio: 4.54 GF Score: 91/100

Exelixis Inc at Truist Securities Life Sciences Summit (May Series) Transcript

May 04, 2021 / 07:30PM GMT
Release Date Price: $23.81 (-3.84%)
Asthika Sarith Goonewardene
Truist Securities, Inc., Research Division - Research Analyst

All right. Let's kick it off. Right. Hello, everyone, and welcome to another session here at the Truist Securities Life Sciences Summit. Great pleasure to have the folks from Exelixis on. For our next session, we have President and CEO, Mike Morrissey. We have Chief Financial Officer, Chris Senner; and we also have Head of Investor Relations, Susan Hubbard, joining us today. Welcome, folks to our Zoom meeting on -- as part of our summit here.

Before we start, I will read out our usual disclaimers. This call is arranged by Truist Securities Research, used by institutional investors and issuer clients as defined by FINRA. If you're not an institutional investor or issuer, please disconnect at this time. For the required disclosures, please see our website at truistsecurities.com or our equity research library.

So, Mike, you have a very active year ahead of us. Why don't you just give -- most people on this call are going to be familiar with Exelixis. Why don't you give us like the quick introduction

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot